Journal articles
Kronenberg-Versteeg D, Eichmann M, Russell MA, de Ru A, Hehn B, Yusuf N, van Veelen PA, Richardson SJ, Morgan NG, Lemburg MK, et al (In Press). Molecular pathways for immune recognition of preproinsulin signal peptide in type 1 diabetes. Diabetes
Sioofy-Khojine A-B, Richardson SJ, Locke JM, Oikarinen S, Nurminen N, Laine A-P, Downes K, Lempainen J, Todd JA, Veijola R, et al (2022). Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stage.
Diabetologia,
65(10), 1701-1709.
Abstract.
Jones AG, Eichmann M (2022). T-Cell Autoreactivity in Type 2 Diabetes: Benign or Pathogenic, Smoke or Fire?. Diabetes, 71(6), 1167-1169.
Arif S, Pujol-Autonell I, Eichmann M (2020). Assessing effector T cells in type 1 diabetes.
Current Opinion in Endocrinology, Diabetes and Obesity,
27(4), 240-247.
Abstract.
Yeo L, Pujol-Autonell I, Baptista R, Eichmann M, Kronenberg-Versteeg D, Heck S, Dolton G, Sewell AK, Harkonen T, Mikk M-L, et al (2020). Circulating β cell-specific CD8<SUP>+</SUP> T cells restricted by high-risk HLA class I molecules show antigen experience in children with and at risk of type 1 diabetes.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY,
199(3), 263-277.
Author URL.
Eichmann M, Baptista R, Ellis RJ, Heck S, Peakman M, Beam CA (2020). Costimulation Blockade Disrupts CD4+ T Cell Memory Pathways and Uncouples Their Link to Decline in β-Cell Function in Type 1 Diabetes.
J Immunol,
204(12), 3129-3138.
Abstract.
Author URL.
Edner NM, Heuts F, Thomas N, Wang CJ, Petersone L, Kenefeck R, Kogimtzis A, Ovcinnikovs V, Ross EM, Ntavli E, et al (2020). Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes.
Nat Immunol,
21(10), 1244-1255.
Abstract.
Author URL.
Yeo L, Woodwyk A, Sood S, Lorenc A, Eichmann M, Pujol-Autonell I, Melchiotti R, Skowera A, Fidanis E, Dolton GM, et al (2018). Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes.
JOURNAL OF CLINICAL INVESTIGATION,
128(8), 3460-3474.
Author URL.
Ali MA, Liu Y-F, Arif S, Tatovic D, Shariff H, Gibson VB, Yusuf N, Baptista R, Eichmann M, Petrov N, et al (2017). Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.
SCIENCE TRANSLATIONAL MEDICINE,
9(402).
Author URL.
Harbige J, Eichmann M, Peakman M (2017). New insights into non-conventional epitopes as T cell targets: the missing link for breaking immune tolerance in autoimmune disease?.
JOURNAL OF AUTOIMMUNITY,
84, 12-20.
Author URL.
Gomez-Tourino I, Arif S, Eichmann M, Peakman M (2016). T cells in type 1 diabetes: Instructors, regulators and effectors: a comprehensive review.
JOURNAL OF AUTOIMMUNITY,
66, 7-16.
Author URL.
Knight RR, Dolton G, Kronenberg-Versteeg D, Eichmann M, Zhao M, Huang GC, Beck K, Cole DK, Sewell AK, Skowera A, et al (2015). A distinct immunogenic region of glutamic acid decarboxylase 65 is naturally processed and presented by human islet cells to cytotoxic CD8 T cells.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY,
179(1), 100-107.
Author URL.
Collison JL, Carlin LM, Eichmann M, Geissmann F, Peakman M (2015). Heterogeneity in the Locomotory Behavior of Human Monocyte Subsets over Human Vascular Endothelium in Vitro.
JOURNAL OF IMMUNOLOGY,
195(3), 1162-1170.
Author URL.
Skowera A, Ladell K, McLaren JE, Dolton G, Matthews KK, Gostick E, Kronenberg-Versteeg D, Eichmann M, Knight RR, Heck S, et al (2015). β-Cell-Specific CD8 T Cell Phenotype in Type 1 Diabetes Reflects Chronic Autoantigen Exposure.
DIABETES,
64(3), 916-925.
Author URL.
Eichmann M, de Ru A, van Veelen PA, Peakman M, Kronenberg-Versteeg D (2014). Identification and characterisation of peptide binding motifs of six autoimmune disease-associated human leukocyte antigen-class I molecules including <i>HLA</i>-<i>B</i>*<i>39</i>:<i>06</i>.
TISSUE ANTIGENS,
84(4), 378-388.
Author URL.
Knight RR, Kronenberg D, Zhao M, Huang GC, Eichmann M, Bulek A, Wooldridge L, Cole DK, Sewell AK, Peakman M, et al (2013). Human β-Cell Killing by Autoreactive Preproinsulin-Specific CD8 T Cells is Predominantly Granule-Mediated with the Potency Dependent Upon T-Cell Receptor Avidity.
DIABETES,
62(1), 205-213.
Author URL.
Kronenberg D, Knight RR, Estorninho M, Ellis RJ, Kester MG, de Ru A, Eichmann M, Huang GC, Powrie J, Dayan CM, et al (2012). Circulating Preproinsulin Signal Peptide-Specific CD8 T Cells Restricted by the Susceptibility Molecule HLA-A24 Are Expanded at Onset of Type 1 Diabetes and Kill β-Cells.
DIABETES,
61(7), 1752-1759.
Author URL.
Luber B, Deplazes J, Keller G, Walch A, Rauser S, Eichmann M, Langer R, Hoefler H, Hegewisch-Becker S, Folprecht G, et al (2011). Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
BMC CANCER,
11 Author URL.